Stock 8037 CHINA BIOTECH SERVICES HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases China Biotech Services Holdings Limited

Equities

8037

BMG2152F1014

Delayed Hong Kong S.E.
Other stock markets
 06:21:14 14/05/2024 BST 		5-day change 1st Jan Change
0.35 HKD -5.41% Intraday chart for China Biotech Services Holdings Limited +18.64% -54.55%
03-28 China Biotech Services Holdings Limited Announces Not Recommends Final Dividend for the Year Ended 31 December 2023 CI
03-28 China Biotech Services Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate
AQ
Sumitomo Heavy Industries, Ltd. - Notice Regarding Our First Overseas Introduction of BNCT in the Hainan Medical Tourism Pilot Zone, China
AQ
China Biotech Services : AMDL, a Subsidiary of China Biotech Services, is Exclusively Licensed to Distribute FDA Approved Lung & Colon Cancer Companion Diagnostic Assay in Several Asian Regions Including China
AQ
China Biotech Services (8037.HK): Confident shareholders are taking long on their books in anticipation of promising results to be generated from the double engines of growth on cell therapy and precision diagnostic businesses
AQ
China Biotech Services : Shanghai Longyao Chief Scientist Professor Xuanming Yang published a research article on optimizing CAR-T cells function with independently expressed full-length OX40
AQ
China Biotech Services : LY007 Cell Injection Obtained Clinical Trial Approval Letter
AQ
China Biotech Services : 8037.HK) and National Institute for Viral Disease Control and Prevention (NIVDC) to develop Genetically Engineered Recombinant Vaccine for COVID-19
AQ
China Biotech Services : 8037.HK) cooperates with the National Institute for Viral Disease Control and Prevention, China CDC for developing a new generation of Genetically Engineered Recombinant Vaccine
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 8037 Stock
  4. News China Biotech Services Holdings Limited
  5. Press Releases